S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
DIS   130.89 (-1.12%)
Log in

Inovio Pharmaceuticals Price Target & Analyst Ratings (NASDAQ:INO)

$2.25
-0.11 (-4.66 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$2.23
Now: $2.25
$2.40
50-Day Range
$1.97
MA: $2.24
$2.65
52-Week Range
$1.91
Now: $2.25
$5.68
Volume521,590 shs
Average Volume988,342 shs
Market Capitalization$222.81 million
P/E RatioN/A
Dividend YieldN/A
Beta2.07

Analyst Ratings

Inovio Pharmaceuticals (NASDAQ:INO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Inovio Pharmaceuticals in the last 12 months. Their average twelve-month price target is $7.32, suggesting that the stock has a possible upside of 225.51%. The high price target for INO is $13.00 and the low price target for INO is $3.62. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.32$7.44$8.52$8.16
Price Target Upside: 225.51% upside199.87% upside239.60% upside115.46% upside

Inovio Pharmaceuticals (NASDAQ:INO) Consensus Price Target History

Inovio Pharmaceuticals (NASDAQ:INO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/18/2019HC WainwrightSet Price TargetBuy$13.00Low
9/16/2019CitigroupReiterated RatingBuy$7.00 ➝ $4.00Medium
8/11/2019Maxim GroupReiterated RatingBuy$6.00High
7/17/2019Piper Jaffray CompaniesLower Price TargetOverweight$12.00 ➝ $10.00High
3/25/2019Cantor FitzgeraldInitiated CoverageOverweight$12.00 ➝ $3.62Medium
10/2/2018Stifel NicolausInitiated CoverageBuy ➝ Buy$8.00High
3/15/2018Royal Bank of CanadaBoost Price TargetOutperform$11.00 ➝ $14.00High
(Data available from 10/18/2017 forward)
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel